CN Stock MarketDetailed Quotes

000999 China Resources Sanjiu Medical & Pharmaceutical

Watchlist
  • 45.93
  • -0.06-0.13%
Not Open Nov 4 15:00 CST
58.99BMarket Cap17.30P/E (TTM)

China Resources Sanjiu Medical & Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
6.08%19.74B
7.30%14.11B
14.82%7.29B
36.83%24.74B
53.65%18.61B
56.48%13.15B
49.46%6.35B
16.31%18.08B
7.53%12.11B
6.82%8.4B
Operating revenue
6.08%19.74B
7.30%14.11B
14.82%7.29B
36.83%24.74B
53.65%18.61B
56.48%13.15B
49.46%6.35B
16.31%18.08B
7.53%12.11B
6.82%8.4B
Other operating revenue
----
-32.65%372.96M
----
34.95%901.47M
----
51.43%553.78M
----
-7.14%667.99M
----
5.24%365.69M
Total operating cost
2.97%15.87B
3.32%11.02B
13.81%5.49B
37.80%21.02B
57.00%15.41B
60.36%10.67B
48.74%4.82B
16.69%15.25B
6.66%9.81B
7.04%6.65B
Operating cost
4.13%9.34B
4.28%6.55B
16.46%3.4B
39.14%11.57B
63.79%8.97B
65.75%6.28B
51.22%2.92B
30.83%8.31B
19.66%5.48B
19.71%3.79B
Operating tax surcharges
4.05%201.67M
10.37%149.98M
14.18%75.25M
32.77%274.91M
46.96%193.82M
50.55%135.89M
41.96%65.9M
1.27%207.06M
-0.21%131.88M
-3.98%90.27M
Operating expense
-0.34%4.75B
0.69%3.31B
11.26%1.56B
37.21%6.97B
48.90%4.77B
52.75%3.29B
43.32%1.4B
0.80%5.08B
-9.99%3.2B
-7.95%2.15B
Administration expense
3.26%1.07B
4.25%706.27M
9.57%338.68M
43.92%1.52B
56.99%1.04B
55.50%677.45M
61.69%309.11M
10.81%1.06B
8.35%662.21M
6.53%435.65M
Financial expense
35.06%-13.33M
-87.10%-24.67M
-223.79%-23.66M
-539.25%-24.19M
-91.99%-20.52M
59.86%-13.19M
17.82%-7.31M
114.57%5.51M
65.20%-10.69M
-7.17%-32.85M
-Interest expense (Financial expense)
25.19%65.46M
59.47%43.12M
114.47%20.82M
280.56%80.78M
266.28%52.29M
233.48%27.04M
162.78%9.71M
49.71%21.23M
52.77%14.28M
25.55%8.11M
-Interest Income (Financial expense)
-13.13%-82.31M
-73.62%-68.61M
-201.37%-46.12M
-45.43%-106.86M
-44.37%-72.75M
-7.36%-39.52M
-14.05%-15.3M
-9.32%-73.48M
4.12%-50.4M
10.03%-36.81M
Research and development
11.72%512.18M
10.59%326.46M
3.64%137.42M
20.30%714.5M
29.95%458.44M
37.30%295.21M
27.31%132.6M
6.02%593.94M
-0.65%352.79M
-8.99%215.01M
Credit Impairment Loss
-134.98%-100.3M
-23.97%-72.23M
-19.89%-38.23M
-1,034.45%-67.78M
-42.63%-42.68M
-117.53%-58.27M
-108.67%-31.89M
51.76%-5.97M
-86.39%-29.93M
-43.24%-26.79M
Asset Impairment Loss
-42.05%-110.9M
-40.73%-25.19M
12.92%-20.54M
-24.85%-172.64M
-125.15%-78.07M
23.32%-17.9M
-20.57%-23.59M
46.09%-138.27M
44.66%-34.67M
-63.66%-23.34M
Other net revenue
-75.13%12.83M
233.20%61.3M
45.51%-9.51M
-70.75%35.87M
-59.14%51.59M
-71.69%18.4M
-198.39%-17.46M
18,412.22%122.63M
29.46%126.25M
-32.07%64.98M
Fair value change income
97.33%-176.07K
158.55%2.08M
94.60%-321.82K
-1,209.83%-28.63M
-385.42%-6.6M
-153.74%-3.56M
---5.96M
-48.79%2.58M
-31.88%2.31M
142.89%6.62M
Invest income
-17.88%8.91M
174.96%12.46M
-30.30%2.17M
-59.13%18.24M
-56.42%10.85M
-71.37%4.53M
5.47%3.11M
31.79%44.62M
48.18%24.9M
85.96%15.82M
-Including: Investment income associates
-303.11%-10.62M
-475.05%-7.18M
-235.42%-1.35M
-11.37%5.2M
1,057.82%5.23M
683.83%1.91M
384.54%995.83K
3,057.34%5.87M
-171.35%-545.76K
-62.23%244.09K
Asset deal income
767.93%23.29M
-84.94%321.85K
-10.05%843.5K
-64.28%813.69K
-16.34%2.68M
42.57%2.14M
-4.89%937.69K
167.98%2.28M
193.66%3.21M
1.31%1.5M
Other revenue
16.07%192M
57.30%143.85M
16.61%46.57M
31.50%285.87M
3.10%165.41M
0.32%91.45M
-17.91%39.94M
-5.39%217.39M
3.54%160.43M
-21.34%91.16M
Operating profit
19.58%3.89B
25.95%3.15B
18.76%1.8B
27.35%3.75B
34.20%3.25B
37.68%2.5B
47.46%1.51B
19.21%2.95B
12.27%2.42B
3.91%1.82B
Add:Non operating Income
299.10%108.55M
29.16%25.75M
194.43%11.82M
44.31%51.29M
39.27%27.2M
114.68%19.94M
57.01%4.01M
64.05%35.54M
76.73%19.53M
64.07%9.29M
Less:Non operating expense
-61.15%10.79M
-40.34%14.05M
-18.56%6.56M
159.85%50.21M
99.31%27.77M
158.61%23.55M
95.84%8.06M
-61.33%19.32M
-64.87%13.93M
-26.75%9.1M
Total profit
22.61%3.98B
26.60%3.16B
19.43%1.8B
26.69%3.75B
33.86%3.25B
37.47%2.5B
47.29%1.51B
21.25%2.96B
14.04%2.43B
4.32%1.82B
Less:Income tax cost
33.42%739.89M
33.64%582.11M
24.82%349.98M
24.56%580.97M
23.38%554.54M
18.79%435.57M
59.76%280.39M
35.04%466.43M
28.57%449.47M
4.33%366.68M
Net profit
20.39%3.24B
25.11%2.58B
18.20%1.45B
27.09%3.17B
36.24%2.7B
42.20%2.06B
44.71%1.23B
18.98%2.5B
11.18%1.98B
4.32%1.45B
Net profit from continuing operation
20.39%3.24B
25.11%2.58B
18.20%1.45B
27.09%3.17B
36.24%2.7B
42.20%2.06B
44.71%1.23B
18.98%2.5B
11.18%1.98B
4.32%1.45B
Less:Minority Profit
-2.63%284.88M
-2.21%178.69M
13.91%89.34M
564.91%320.55M
1,031.76%292.58M
1,076.61%182.73M
789.68%78.43M
10.85%48.21M
11.98%25.85M
21.24%15.53M
Net profit of parent company owners
23.19%2.96B
27.77%2.4B
18.49%1.36B
16.50%2.85B
23.06%2.4B
30.99%1.88B
36.90%1.15B
19.16%2.45B
11.17%1.95B
4.16%1.43B
Earning per share
Basic earning per share
23.40%2.32
27.21%1.87
19.83%1.39
16.94%2.9
-5.53%1.88
0.68%1.47
34.88%1.16
18.10%2.48
11.17%1.99
3.55%1.46
Diluted earning per share
23.40%2.32
27.21%1.87
19.83%1.39
16.94%2.9
-5.53%1.88
0.68%1.47
34.88%1.16
18.10%2.48
11.17%1.99
3.55%1.46
Other composite income
-125.01%-1.15M
-100.41%-29.84K
97.77%-96.17K
-107.40%-5.21M
-87.37%4.61M
1,703.99%7.23M
-6,656.29%-4.32M
1,273.94%70.39M
307.34%36.48M
-40.98%400.52K
Other composite income of parent company owners
-107.83%-422.07K
-99.37%43.04K
99.49%-21.16K
-99.06%664.35K
-85.23%5.39M
1,593.27%6.78M
-6,356.30%-4.12M
1,259.34%70.38M
307.34%36.48M
-40.98%400.52K
Other composite income of minority owners
6.56%-730.44K
-116.43%-72.88K
60.86%-75K
-67,478.48%-5.87M
---781.74K
--443.47K
---191.64K
116.03%8.72K
----
----
Total composite income
20.14%3.24B
24.67%2.58B
18.60%1.45B
23.40%3.17B
34.01%2.7B
42.66%2.07B
44.21%1.23B
22.04%2.57B
12.66%2.01B
4.30%1.45B
Total composite income of parent company owners
22.90%2.96B
27.31%2.4B
18.91%1.36B
13.27%2.85B
21.08%2.41B
31.42%1.88B
36.42%1.15B
22.27%2.52B
12.67%1.99B
4.14%1.43B
Total composite income of minority owners
-2.62%284.15M
-2.49%178.62M
14.10%89.27M
552.61%314.67M
1,028.73%291.8M
1,079.46%183.18M
787.51%78.24M
11.01%48.22M
11.98%25.85M
21.24%15.53M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 6.08%19.74B7.30%14.11B14.82%7.29B36.83%24.74B53.65%18.61B56.48%13.15B49.46%6.35B16.31%18.08B7.53%12.11B6.82%8.4B
Operating revenue 6.08%19.74B7.30%14.11B14.82%7.29B36.83%24.74B53.65%18.61B56.48%13.15B49.46%6.35B16.31%18.08B7.53%12.11B6.82%8.4B
Other operating revenue -----32.65%372.96M----34.95%901.47M----51.43%553.78M-----7.14%667.99M----5.24%365.69M
Total operating cost 2.97%15.87B3.32%11.02B13.81%5.49B37.80%21.02B57.00%15.41B60.36%10.67B48.74%4.82B16.69%15.25B6.66%9.81B7.04%6.65B
Operating cost 4.13%9.34B4.28%6.55B16.46%3.4B39.14%11.57B63.79%8.97B65.75%6.28B51.22%2.92B30.83%8.31B19.66%5.48B19.71%3.79B
Operating tax surcharges 4.05%201.67M10.37%149.98M14.18%75.25M32.77%274.91M46.96%193.82M50.55%135.89M41.96%65.9M1.27%207.06M-0.21%131.88M-3.98%90.27M
Operating expense -0.34%4.75B0.69%3.31B11.26%1.56B37.21%6.97B48.90%4.77B52.75%3.29B43.32%1.4B0.80%5.08B-9.99%3.2B-7.95%2.15B
Administration expense 3.26%1.07B4.25%706.27M9.57%338.68M43.92%1.52B56.99%1.04B55.50%677.45M61.69%309.11M10.81%1.06B8.35%662.21M6.53%435.65M
Financial expense 35.06%-13.33M-87.10%-24.67M-223.79%-23.66M-539.25%-24.19M-91.99%-20.52M59.86%-13.19M17.82%-7.31M114.57%5.51M65.20%-10.69M-7.17%-32.85M
-Interest expense (Financial expense) 25.19%65.46M59.47%43.12M114.47%20.82M280.56%80.78M266.28%52.29M233.48%27.04M162.78%9.71M49.71%21.23M52.77%14.28M25.55%8.11M
-Interest Income (Financial expense) -13.13%-82.31M-73.62%-68.61M-201.37%-46.12M-45.43%-106.86M-44.37%-72.75M-7.36%-39.52M-14.05%-15.3M-9.32%-73.48M4.12%-50.4M10.03%-36.81M
Research and development 11.72%512.18M10.59%326.46M3.64%137.42M20.30%714.5M29.95%458.44M37.30%295.21M27.31%132.6M6.02%593.94M-0.65%352.79M-8.99%215.01M
Credit Impairment Loss -134.98%-100.3M-23.97%-72.23M-19.89%-38.23M-1,034.45%-67.78M-42.63%-42.68M-117.53%-58.27M-108.67%-31.89M51.76%-5.97M-86.39%-29.93M-43.24%-26.79M
Asset Impairment Loss -42.05%-110.9M-40.73%-25.19M12.92%-20.54M-24.85%-172.64M-125.15%-78.07M23.32%-17.9M-20.57%-23.59M46.09%-138.27M44.66%-34.67M-63.66%-23.34M
Other net revenue -75.13%12.83M233.20%61.3M45.51%-9.51M-70.75%35.87M-59.14%51.59M-71.69%18.4M-198.39%-17.46M18,412.22%122.63M29.46%126.25M-32.07%64.98M
Fair value change income 97.33%-176.07K158.55%2.08M94.60%-321.82K-1,209.83%-28.63M-385.42%-6.6M-153.74%-3.56M---5.96M-48.79%2.58M-31.88%2.31M142.89%6.62M
Invest income -17.88%8.91M174.96%12.46M-30.30%2.17M-59.13%18.24M-56.42%10.85M-71.37%4.53M5.47%3.11M31.79%44.62M48.18%24.9M85.96%15.82M
-Including: Investment income associates -303.11%-10.62M-475.05%-7.18M-235.42%-1.35M-11.37%5.2M1,057.82%5.23M683.83%1.91M384.54%995.83K3,057.34%5.87M-171.35%-545.76K-62.23%244.09K
Asset deal income 767.93%23.29M-84.94%321.85K-10.05%843.5K-64.28%813.69K-16.34%2.68M42.57%2.14M-4.89%937.69K167.98%2.28M193.66%3.21M1.31%1.5M
Other revenue 16.07%192M57.30%143.85M16.61%46.57M31.50%285.87M3.10%165.41M0.32%91.45M-17.91%39.94M-5.39%217.39M3.54%160.43M-21.34%91.16M
Operating profit 19.58%3.89B25.95%3.15B18.76%1.8B27.35%3.75B34.20%3.25B37.68%2.5B47.46%1.51B19.21%2.95B12.27%2.42B3.91%1.82B
Add:Non operating Income 299.10%108.55M29.16%25.75M194.43%11.82M44.31%51.29M39.27%27.2M114.68%19.94M57.01%4.01M64.05%35.54M76.73%19.53M64.07%9.29M
Less:Non operating expense -61.15%10.79M-40.34%14.05M-18.56%6.56M159.85%50.21M99.31%27.77M158.61%23.55M95.84%8.06M-61.33%19.32M-64.87%13.93M-26.75%9.1M
Total profit 22.61%3.98B26.60%3.16B19.43%1.8B26.69%3.75B33.86%3.25B37.47%2.5B47.29%1.51B21.25%2.96B14.04%2.43B4.32%1.82B
Less:Income tax cost 33.42%739.89M33.64%582.11M24.82%349.98M24.56%580.97M23.38%554.54M18.79%435.57M59.76%280.39M35.04%466.43M28.57%449.47M4.33%366.68M
Net profit 20.39%3.24B25.11%2.58B18.20%1.45B27.09%3.17B36.24%2.7B42.20%2.06B44.71%1.23B18.98%2.5B11.18%1.98B4.32%1.45B
Net profit from continuing operation 20.39%3.24B25.11%2.58B18.20%1.45B27.09%3.17B36.24%2.7B42.20%2.06B44.71%1.23B18.98%2.5B11.18%1.98B4.32%1.45B
Less:Minority Profit -2.63%284.88M-2.21%178.69M13.91%89.34M564.91%320.55M1,031.76%292.58M1,076.61%182.73M789.68%78.43M10.85%48.21M11.98%25.85M21.24%15.53M
Net profit of parent company owners 23.19%2.96B27.77%2.4B18.49%1.36B16.50%2.85B23.06%2.4B30.99%1.88B36.90%1.15B19.16%2.45B11.17%1.95B4.16%1.43B
Earning per share
Basic earning per share 23.40%2.3227.21%1.8719.83%1.3916.94%2.9-5.53%1.880.68%1.4734.88%1.1618.10%2.4811.17%1.993.55%1.46
Diluted earning per share 23.40%2.3227.21%1.8719.83%1.3916.94%2.9-5.53%1.880.68%1.4734.88%1.1618.10%2.4811.17%1.993.55%1.46
Other composite income -125.01%-1.15M-100.41%-29.84K97.77%-96.17K-107.40%-5.21M-87.37%4.61M1,703.99%7.23M-6,656.29%-4.32M1,273.94%70.39M307.34%36.48M-40.98%400.52K
Other composite income of parent company owners -107.83%-422.07K-99.37%43.04K99.49%-21.16K-99.06%664.35K-85.23%5.39M1,593.27%6.78M-6,356.30%-4.12M1,259.34%70.38M307.34%36.48M-40.98%400.52K
Other composite income of minority owners 6.56%-730.44K-116.43%-72.88K60.86%-75K-67,478.48%-5.87M---781.74K--443.47K---191.64K116.03%8.72K--------
Total composite income 20.14%3.24B24.67%2.58B18.60%1.45B23.40%3.17B34.01%2.7B42.66%2.07B44.21%1.23B22.04%2.57B12.66%2.01B4.30%1.45B
Total composite income of parent company owners 22.90%2.96B27.31%2.4B18.91%1.36B13.27%2.85B21.08%2.41B31.42%1.88B36.42%1.15B22.27%2.52B12.67%1.99B4.14%1.43B
Total composite income of minority owners -2.62%284.15M-2.49%178.62M14.10%89.27M552.61%314.67M1,028.73%291.8M1,079.46%183.18M787.51%78.24M11.01%48.22M11.98%25.85M21.24%15.53M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data